Tripodi V, Contin M, Fernández MA, Lemberg A

Language: English
References: 21
Page: 930-934
PDF size: 86.29 Kb.

ABSTRACT

Introduction. Cholestasis leads to liver cell death, fibrosis, cirrhosis, and eventually liver failure. Bile duct ligated rats constitute an interesting model to study the mechanism of cholestasis, and its action on several organs and tissues, including the brain. Aim. To analyze brain bile acids individually in ligated rats to evaluate if its profile is altered towards a more toxic condition in cholestasis. Material and methods. Male Wistar rats were used and separated in two groups: bile duct ligated rats and sham operated rats (n = 5 in each group). Bile acid profile was assessed in brain homogenates. Alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase determinations, bilirubin and ammonia plasma concentration were also measured in both groups. Results. Although the total amount of bile acids in control animal brains showed a higher concentration than in bile duct ligated rats, the bile acid profile in this group was found more toxic composition than in controls. Lithocholic acid was present in brain in higher concentration (87.4 % of total brain bile acids) in ligated rats and absent in controls. Alkaline phosphatase, bilirubin and ammonia were significantly higher in bile duct ligated rats than in control group. Conclusion. It was found a toxic brain bile acid profile during hepatic cholestasis which could be one of the explanations of hepatic encephalopathy observed in cholestatic diseases.

REFERENCES

1. Lemberg A, Fernández M. Hepatic encephalopathy, ammonia, glutamate, glutamine and oxidative stress. Ann Hepatol 2009; 8(2): 95-102.

2. Jover R, Rodrigo R, Felipo V, Insausti R, Sáez-Valero J, García-Ayllón MS, Suárez I, et al. Brain edema and inflammatory activation in bile duct ligated rats with diet-induced hyperammonemia: A model of hepatic encephalopathy in cirrhosis. Hepatology 2006; 43(6): 1257-66.

3. Zaki AE, Wardle EN, Canalese J, Ede RJ, Williams R. Potential toxins of acute liver failure and their effects on bloodbrain barrier permeability. Experientia 1983; 39(9): 988-91.

4. Tominaga S, Watanabe A, Tsujit T. Synergistic effect of bile acid, endotoxin and ammonia on brain edema. Metab Brain Dis 1991; 6(2): 93-105.

5. Mano N, Goto T, Uchida M, Nishimura K, Ando M, Kobayashi N, Goto J. Presence of protein-bound unconjugated bile acids in the cytoplasmic fraction of rat brain. J Lip Res 2004; 45(2): 295-300.

6. Hofmann A. Bile acids: the good, the bad and the ugly. News Physiol Sci 1999; 14: 24-29.

7. Trottier J, Bia³ek A, Caron P, Straka RJ, Milkiewicz P, Barbier O. Profiling circulating and urinary bile acids in patients with biliary obstruction before and after biliary stenting. PLoS ONE 2011; 6(7): e22094 doi:10.1371/ journal.pone.0022094.

8. Naqvi SH, Herndon BL, Kelley MT, Bleisch V, Aexel RT, Nicholas HJ. Detection of monohydroxy bile acids in the brains of guinea pigs afflicted with experimental allergic encephalomyelitis. J Lipid Research 1969; 10: 115-20.

9. Tripodi V, Lucangioli S, Scioscia S, Carducci C. Simultaneous determination of free and conjugated bile acids in serum by cyclodextrin-modified micellar electrokinetic chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 2003; 785(1): 147-55.

10. Castaño G, Lucangioli S, Sookoian S, Mesquida M, Lemberg A, Di Scala M, Franchi P, et al. Bile acid profiles by capillary electrophoresis in intrahepatic cholestasis of pregnancy. Clin Sci 2006; 110: 459-65.

11. Lucangioli S, Castaño G, Contin M, Tripodi V. Lithocholic acid as a biomarker of intrahepatic cholestasis of pregnancy during ursodeoxycholic acid treatment. Ann Clin Biochem 2009; 46: 44-9.

12. Lucangioli S, Carducci C, Tripodi V, Kebbdler E. Retention of bile salts in micellar electrokinetic chromatography: relation of capacity factor to octanol-water partition coefficient and critical micellar concentration. J Chromatogr B 2001; 765: 113-20.

13. Ceryak S, Bouscarel B, Malavolti M, Fromm H. Extrahepatic deposition and cytotoxicity of lithocholic acid: studies in two hamster models of hepatic failure and in cultured human fibroblasts. Hepatology 1998; 27(2): 546-56.

14. Krähenbühl S, Talos C, Lauterburg BH, Reichen J. Reduced antioxidative capacity in liver mitochondria from bile duct ligated rats. Hepatology 1995; 22: 607-12.

15. Velardi AL, Groen AK, Elferink RP, van der Meer R, Palasciano G, Tytgat GN.Cell type-dependent effect of phospholipid and cholesterol on bile salt cytotoxocity. Gastroenterol 1991; 101: 457-64.

16. Van Dyke R, Stephens J, Scharschmidt B. Bile acid transport in cultured rat hepatocytes. Am J Physiol 1982; 243: G484-G492.

17. Aldini R, Roda A, Montagnani M, Cerre C, Pellicciari R, Roda E. Relationship between structure and intestinal absorption of bile acids with a steroid or side chain-modification. Steroids 1996; 61: 590-7.

18. Stolz A, Takikawa H, Ookhtens M, Kaplowitz N. The role of cytoplasmic proteins in hepatic bile acid transport. Annu Rev Physiol 1989; 51: 161-76.

19. Krähenbühl S, Talos C, Fischer S, Reichen J. Toxicity of bile acids on the electron transport chain of isolated rat liver mitochondria. Hepatology 1994; 19: 471-9.

20. Weil A. The effect of hemolytic toxins on nervous tissue. Arch Pathol 1929; 9: 828-42.

21. Nicholas H, Herndon B. Cholic acid as a demyelinating agent in vivo. Neurology 1964; 14: 549-54.